Back to Journals » Journal of Inflammation Research » Volume 9

Familial Mediterranean fever: current perspectives

Authors Sonmez H, Batu E, Ozen S

Received 13 October 2015

Accepted for publication 21 November 2015

Published 17 March 2016 Volume 2016:9 Pages 13—20

DOI https://doi.org/10.2147/JIR.S91352

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Tahseen Nasti

Peer reviewer comments 2

Editor who approved publication: Dr Ning Quan


Hafize Emine Sönmez,* Ezgi Deniz Batu,* Seza Özen

Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey

*These authors contributed equally to this work

Abstract: Familial Mediterranean fever (FMF) is the most frequent monogenic autoinflammatory disease, and it is characterized by recurrent attacks of fever and polyserositis. The disease is associated with mutations in the MEFV gene encoding pyrin, which causes exaggerated inflammatory response through uncontrolled production of interleukin 1. The major long-term complication of FMF is amyloidosis. Colchicine remains the principle therapy, and the aim of treatment is to prevent acute attacks and the consequences of chronic inflammation. With the evolution in the concepts about the etiopathogenesis and genetics of the disease, we have understood that FMF is more complicated than an ordinary autosomal recessive monogenic disorder. Recently, recommendation sets have been generated for interpretation of genetic testing and genetic diagnosis of FMF. Here, we have reviewed the current perspectives in FMF in light of recent recommendations.

Keywords: familial Meditarranean fever, recommendation, child

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]